Esperion Therapeutics, Inc. (ESPR)
Since Aug 12, 2013, Esperion Therapeutics, Inc. (ESPR) has reported earnings 50 times. On average the shares move ±7.40% post-earnings, with a positive reaction 66.0% of the time. Its largest post-earnings gain was +15.41% (Aug 08, 2017) and its largest decline was -35.11% (May 02, 2018). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
50
Avg Abs. Movement
±7.40%
Positive %
66.0%
Negative %
34.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | ☀ PRE | $3.12 | $3.27 | $2.70 | 10,098,400 | -11.18% | open_in_new |
| Nov 06, 2025 | ☀ PRE | $2.76 | $2.78 | $2.50 | 11,799,500 | -14.97% | open_in_new |
| Aug 05, 2025 | ☀ PRE | $1.63 | $1.72 | $1.62 | 8,203,800 | +8.72% | open_in_new |
| May 06, 2025 | ☀ PRE | $1.01 | $1.05 | $0.98 | 4,748,700 | -6.67% | open_in_new |
| Mar 04, 2025 | ☀ PRE | $1.65 | $1.86 | $1.77 | 5,841,100 | +12.03% | open_in_new |
| Nov 07, 2024 | ☀ PRE | $2.03 | $2.14 | $2.11 | 11,884,500 | -4.52% | open_in_new |
| Aug 12, 2024 | ☀ PRE | $1.86 | $2.00 | $1.84 | 9,258,900 | -8.91% | open_in_new |
| May 07, 2024 | ☀ PRE | $2.38 | $2.53 | $2.37 | 45,902,500 | +11.79% | open_in_new |
| Feb 27, 2024 | ☀ PRE | $2.64 | $3.00 | $2.90 | 9,893,500 | +10.27% | open_in_new |
| Nov 07, 2023 | ☀ PRE | $1.06 | $1.10 | $1.03 | 2,978,800 | +7.29% | open_in_new |
| Aug 01, 2023 | ☀ PRE | $1.69 | $1.87 | $1.69 | 8,915,900 | +7.64% | open_in_new |
| May 09, 2023 | ☀ PRE | $1.40 | $1.46 | $1.42 | 2,405,700 | +5.19% | open_in_new |
| Feb 21, 2023 | ☀ PRE | $5.90 | $6.01 | $5.59 | 3,271,600 | -5.57% | open_in_new |
| Nov 01, 2022 | ☀ PRE | $7.97 | $8.85 | $8.28 | 2,217,000 | +1.85% | open_in_new |
| Aug 02, 2022 | ☀ PRE | $5.80 | $6.06 | $5.87 | 878,300 | +7.71% | open_in_new |
| May 03, 2022 | ☀ PRE | $5.80 | $6.56 | $6.53 | 2,331,100 | +13.96% | open_in_new |
| Feb 22, 2022 | ☀ PRE | $4.28 | $4.43 | $4.36 | 2,111,900 | +13.54% | open_in_new |
| Nov 02, 2021 | ☀ PRE | $8.91 | $10.65 | $10.31 | 1,527,000 | +1.98% | open_in_new |
| Aug 03, 2021 | ☀ PRE | $15.68 | $15.89 | $14.27 | 1,422,600 | -4.8% | open_in_new |
| May 04, 2021 | ☽ POST | $26.62 | $26.81 | $25.59 | 819,200 | -21.81% | open_in_new |
| Feb 23, 2021 | ☽ POST | $28.60 | $29.00 | $27.88 | 832,500 | +2.4% | open_in_new |
| Nov 02, 2020 | ☽ POST | $30.05 | $30.63 | $28.99 | 714,600 | -16.52% | open_in_new |
| Aug 10, 2020 | ☽ POST | $38.09 | $38.50 | $37.00 | 997,500 | -9.51% | open_in_new |
| May 06, 2020 | ☽ POST | $40.95 | $41.95 | $40.60 | 487,000 | +8.67% | open_in_new |
| Feb 27, 2020 | ☀ PRE | $52.99 | $55.48 | $52.30 | 1,796,700 | -8.33% | open_in_new |
| Nov 06, 2019 | ☀ PRE | $38.87 | $39.50 | $37.30 | 768,700 | -8.65% | open_in_new |
| Aug 08, 2019 | ☀ PRE | $38.04 | $40.27 | $39.02 | 451,500 | +1.4% | open_in_new |
| May 08, 2019 | ☀ PRE | $49.50 | $50.95 | $50.46 | 935,100 | +4.28% | open_in_new |
| Feb 28, 2019 | ☽ POST | $46.71 | $46.75 | $46.10 | 426,800 | +2.56% | open_in_new |
| Nov 01, 2018 | ☽ POST | $46.00 | $50.10 | $49.94 | 957,600 | +11.89% | open_in_new |
| Aug 02, 2018 | ☀ PRE | $44.82 | $48.47 | $47.72 | 1,327,900 | +6.64% | open_in_new |
| May 02, 2018 | ☀ PRE | $46.55 | $57.15 | $45.75 | 14,590,900 | -35.11% | open_in_new |
| Feb 20, 2018 | ☀ PRE | $74.10 | $80.74 | $75.79 | 1,242,400 | +1.16% | open_in_new |
| Nov 07, 2017 | ☀ PRE | $48.52 | $51.33 | $49.15 | 635,400 | +1.32% | open_in_new |
| Aug 08, 2017 | ☀ PRE | $51.10 | $57.38 | $52.13 | 4,170,600 | +15.41% | open_in_new |
| May 04, 2017 | ☽ POST | $37.62 | $37.95 | $36.94 | 692,200 | -5.22% | open_in_new |
| Feb 22, 2017 | ☀ PRE | $23.73 | $24.34 | $22.53 | 1,469,400 | -7.74% | open_in_new |
| Nov 03, 2016 | ☽ POST | $10.34 | $10.39 | $9.40 | 393,700 | +5.53% | open_in_new |
| Aug 04, 2016 | ☽ POST | $11.31 | $11.50 | $10.97 | 167,600 | +1.64% | open_in_new |
| May 04, 2016 | ☀ PRE | $15.35 | $15.44 | $14.37 | 1,252,000 | -7.71% | open_in_new |
| Feb 25, 2016 | ☽ POST | $15.96 | $16.46 | $14.97 | 485,500 | +3.81% | open_in_new |
| Nov 05, 2015 | ☽ POST | $29.29 | $29.49 | $27.50 | 916,300 | +0.98% | open_in_new |
| Aug 06, 2015 | ☽ POST | $59.99 | $60.70 | $55.61 | 1,300,800 | +5.63% | open_in_new |
| May 07, 2015 | ☽ POST | $101.01 | $101.75 | $99.98 | 584,500 | +3.56% | open_in_new |
| Mar 19, 2015 | ☽ POST | $108.61 | $118.95 | $110.14 | 6,048,400 | +1.99% | open_in_new |
| Nov 10, 2014 | ☽ POST | $25.68 | $26.18 | $25.83 | 208,500 | +7.32% | open_in_new |
| Aug 12, 2014 | ☽ POST | $15.81 | $15.91 | $15.86 | 21,200 | +1.39% | open_in_new |
| May 12, 2014 | ☽ POST | $13.86 | $14.46 | $14.23 | 29,200 | +0.07% | open_in_new |
| Nov 06, 2013 | ☽ POST | $15.42 | $15.80 | $14.77 | 61,700 | -1.76% | open_in_new |
| Aug 12, 2013 | ☽ POST | $16.64 | $17.50 | $17.23 | 19,400 | +1.22% | open_in_new |
Earnings Count
50
Total earnings in dataset
Avg Abs. Movement
±7.40%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260609 | open_in_new SEC.gov |
| DEFM14A | 20260608 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260608 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 8-K | 20260601 | open_in_new SEC.gov |
| PREM14A | 20260529 | open_in_new SEC.gov |
Frequently asked about ESPR earnings
When does Esperion Therapeutics, Inc. report earnings next? expand_more
Esperion Therapeutics, Inc. (ESPR)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ESPR stock move after earnings? expand_more
Over 50 reports, ESPR has moved an average of ±7.40% the session after earnings, closing higher 66.0% of the time.
What was ESPR's biggest post-earnings move? expand_more
ESPR's largest post-earnings gain on record was +15.41% on Aug 08, 2017, and its largest decline was -35.11% on May 02, 2018.
Where can I find Esperion Therapeutics, Inc.'s SEC filings? expand_more
All of Esperion Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right